Barrett & Company’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Barrett & Company’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.1K	Hold	125	–	–	﹤0.01%	516
2026 Q1	$5.47K	Hold	125	–	–	﹤0.01%	514
2025 Q4	$5.68K	Hold	125	–	–	﹤0.01%	517
2025 Q3	$4.85K	Hold	125	–	–	﹤0.01%	528
2025 Q2	$4.21K	Hold	125	–	–	﹤0.01%	544
2025 Q1	$3.98K	Hold	125	–	–	﹤0.01%	517
2024 Q4	$4.86K	Hold	125	–	–	﹤0.01%	498
2024 Q3	$5.63K	Hold	125	–	–	﹤0.01%	475
2024 Q2	$5.22K	Hold	125	–	–	﹤0.01%	482
2024 Q1	$5.69K	Hold	125	–	–	﹤0.01%	479
2023 Q4	$5.78K	Hold	125	–	–	﹤0.01%	463
2023 Q3	$5.08K	Hold	125	–	–	﹤0.01%	482
2023 Q2	$6.06K	Buy	+125	New	+$6.25K	﹤0.01%	455

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Barrett & Company's GNOM Position: Q2 2026 in Review

Barrett & Company held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 125 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #516.

Barrett & Company first reported a position in GNOM in Q2 2023 and has held it in 13 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Barrett & Company held 125 shares of Global X Genomics & Biotechnology ETF worth $7.1K as of Q2 2026.
Barrett & Company left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Barrett & Company's portfolio in Q2 2026, its #516 holding.
Barrett & Company first reported a position in Global X Genomics & Biotechnology ETF in Q2 2023 and has held it in 13 quarters since.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Barrett & Company's 13F filing for Q2 2026, filed 24 Jul 2026.